KMB

KMB
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.133B ▼ | $855M ▼ | $446M ▼ | 10.791% ▼ | $1.34 ▼ | $833M ▲ |
| Q2-2025 | $4.163B ▼ | $864M ▼ | $509M ▼ | 12.227% ▲ | $1.53 ▼ | $802M ▼ |
| Q1-2025 | $4.84B ▼ | $964M ▼ | $567M ▲ | 11.715% ▲ | $1.71 ▲ | $976M ▲ |
| Q4-2024 | $4.928B ▼ | $1.127B ▲ | $447M ▼ | 9.071% ▼ | $1.34 ▼ | $760M ▼ |
| Q3-2024 | $4.952B | $630M | $907M | 18.316% | $2.7 | $1.348B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $617M ▼ | $16.888B ▲ | $15.556B ▲ | $1.332B ▲ |
| Q2-2025 | $634M ▲ | $16.771B ▲ | $15.368B ▲ | $1.271B ▲ |
| Q1-2025 | $563M ▼ | $16.305B ▼ | $15.081B ▼ | $1.101B ▲ |
| Q4-2024 | $1.021B ▼ | $16.546B ▼ | $15.571B ▼ | $840M ▼ |
| Q3-2024 | $1.111B | $17.165B | $15.721B | $1.285B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $454M ▼ | $708M ▼ | $312M ▲ | $1.183B ▲ | $-40M ▼ | $1.109B ▲ |
| Q2-2025 | $512M ▼ | $770M ▲ | $-193M ▼ | $-500M ▲ | $94M ▲ | $573M ▲ |
| Q1-2025 | $573M ▲ | $327M ▼ | $-119M ▲ | $-683M ▲ | $-458M ▼ | $123M ▼ |
| Q4-2024 | $452M ▼ | $817M ▼ | $-194M ▼ | $-686M ▲ | $-90M ▼ | $608M ▼ |
| Q3-2024 | $935M | $958M | $470M | $-1.482B | $-52M | $798M |
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Consumer Tissue | $1.60Bn ▲ | $1.50Bn ▼ | $1.54Bn ▲ | $1.52Bn ▼ |
KC Professional | $820.00M ▲ | $800.00M ▼ | $770.00M ▼ | $0 ▼ |
Personal Care | $2.71Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, Kimberly-Clark looks like a classic, mature consumer defensive company that is working to modernize itself. Revenue growth has been modest, but profitability has improved as the company manages costs and pricing more effectively. Its balance sheet leans heavily on debt, which is worth monitoring, but cash flows are robust and relatively resilient. Strong brands, a wide geographic footprint, and a clear innovation and sustainability agenda support its long-term positioning, even in a crowded and price-sensitive market. The main areas to watch are: the durability of recent margin gains, the impact of higher capital spending on returns and leverage, and the company’s ability to keep its brands compelling as consumer preferences and economic conditions shift.
NEWS
November 21, 2025 · 4:10 PM UTC
Kimberly-Clark To Webcast Its Presentation At Morgan Stanley's Global Consumer & Retail Conference
Read more
November 20, 2025 · 4:10 PM UTC
Kimberly-Clark Declares Quarterly Dividend
Read more
November 4, 2025 · 6:00 PM UTC
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kimberly-Clark Corporation (NASDAQ: KMB)
Read more
November 3, 2025 · 7:11 PM UTC
Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE
Read more
November 3, 2025 · 4:58 PM UTC
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.
Read more
About Kimberly-Clark Corporation
https://www.kimberly-clark.comKimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.133B ▼ | $855M ▼ | $446M ▼ | 10.791% ▼ | $1.34 ▼ | $833M ▲ |
| Q2-2025 | $4.163B ▼ | $864M ▼ | $509M ▼ | 12.227% ▲ | $1.53 ▼ | $802M ▼ |
| Q1-2025 | $4.84B ▼ | $964M ▼ | $567M ▲ | 11.715% ▲ | $1.71 ▲ | $976M ▲ |
| Q4-2024 | $4.928B ▼ | $1.127B ▲ | $447M ▼ | 9.071% ▼ | $1.34 ▼ | $760M ▼ |
| Q3-2024 | $4.952B | $630M | $907M | 18.316% | $2.7 | $1.348B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $617M ▼ | $16.888B ▲ | $15.556B ▲ | $1.332B ▲ |
| Q2-2025 | $634M ▲ | $16.771B ▲ | $15.368B ▲ | $1.271B ▲ |
| Q1-2025 | $563M ▼ | $16.305B ▼ | $15.081B ▼ | $1.101B ▲ |
| Q4-2024 | $1.021B ▼ | $16.546B ▼ | $15.571B ▼ | $840M ▼ |
| Q3-2024 | $1.111B | $17.165B | $15.721B | $1.285B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $454M ▼ | $708M ▼ | $312M ▲ | $1.183B ▲ | $-40M ▼ | $1.109B ▲ |
| Q2-2025 | $512M ▼ | $770M ▲ | $-193M ▼ | $-500M ▲ | $94M ▲ | $573M ▲ |
| Q1-2025 | $573M ▲ | $327M ▼ | $-119M ▲ | $-683M ▲ | $-458M ▼ | $123M ▼ |
| Q4-2024 | $452M ▼ | $817M ▼ | $-194M ▼ | $-686M ▲ | $-90M ▼ | $608M ▼ |
| Q3-2024 | $935M | $958M | $470M | $-1.482B | $-52M | $798M |
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Consumer Tissue | $1.60Bn ▲ | $1.50Bn ▼ | $1.54Bn ▲ | $1.52Bn ▼ |
KC Professional | $820.00M ▲ | $800.00M ▼ | $770.00M ▼ | $0 ▼ |
Personal Care | $2.71Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, Kimberly-Clark looks like a classic, mature consumer defensive company that is working to modernize itself. Revenue growth has been modest, but profitability has improved as the company manages costs and pricing more effectively. Its balance sheet leans heavily on debt, which is worth monitoring, but cash flows are robust and relatively resilient. Strong brands, a wide geographic footprint, and a clear innovation and sustainability agenda support its long-term positioning, even in a crowded and price-sensitive market. The main areas to watch are: the durability of recent margin gains, the impact of higher capital spending on returns and leverage, and the company’s ability to keep its brands compelling as consumer preferences and economic conditions shift.
NEWS
November 21, 2025 · 4:10 PM UTC
Kimberly-Clark To Webcast Its Presentation At Morgan Stanley's Global Consumer & Retail Conference
Read more
November 20, 2025 · 4:10 PM UTC
Kimberly-Clark Declares Quarterly Dividend
Read more
November 4, 2025 · 6:00 PM UTC
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kimberly-Clark Corporation (NASDAQ: KMB)
Read more
November 3, 2025 · 7:11 PM UTC
Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE
Read more
November 3, 2025 · 4:58 PM UTC
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.
Read more

CEO
Michael D. Hsu
Compensation Summary
(Year 2024)

CEO
Michael D. Hsu
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-11-03 | Forward | 1043:1000 |
| 1997-04-03 | Forward | 2:1 |
| 1992-01-03 | Forward | 2:1 |
| 1987-05-26 | Forward | 2:1 |
| 1984-05-25 | Forward | 2:1 |
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades

Argus Research
Buy

RBC Capital
Outperform

Piper Sandler
Overweight

Wells Fargo
Equal Weight

Morgan Stanley
Equal Weight

Barclays
Equal Weight

Evercore ISI Group
In Line

UBS
Neutral

JP Morgan
Neutral

TD Cowen
Hold

Citigroup
Sell
Grade Summary
Price Target
Institutional Ownership

VANGUARD GROUP INC
40.531M Shares
$4.423B

BLACKROCK INC.
31.389M Shares
$3.425B

BLACKROCK, INC.
28.111M Shares
$3.067B

STATE STREET CORP
20.831M Shares
$2.273B

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
11.618M Shares
$1.268B

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
9.861M Shares
$1.076B

BLACKROCK FUND ADVISORS
9.761M Shares
$1.065B

GEODE CAPITAL MANAGEMENT, LLC
8.257M Shares
$900.958M

PRICE T ROWE ASSOCIATES INC /MD/
8.056M Shares
$879.045M

MORGAN STANLEY
6.098M Shares
$665.397M

AMERICAN CENTURY INVESTMENT MANAGEMENT INC
5.828M Shares
$635.984M

INVESCO LTD.
5.775M Shares
$630.12M

MASSACHUSETTS FINANCIAL SERVICES CO /MA/
5.211M Shares
$568.664M

CAPITAL WORLD INVESTORS
4.941M Shares
$539.156M

NORGES BANK
4.314M Shares
$470.704M

NORTHERN TRUST CORP
3.89M Shares
$424.498M

BANK OF AMERICA CORP /DE/
3.633M Shares
$396.453M

MANAGED ACCOUNT ADVISORS LLC
3.599M Shares
$392.709M

UBS ASSET MANAGEMENT AMERICAS INC
3.47M Shares
$378.593M

BLACKROCK GROUP LTD
3.394M Shares
$370.319M
Summary
Only Showing The Top 20




